Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases.

Serini S, Cassano R, Trombino S, Calviello G.

Int J Nanomedicine. 2019 Apr 23;14:2809-2828. doi: 10.2147/IJN.S197499. eCollection 2019. Review.

2.

Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system.

Darwesh AM, Sosnowski DK, Lee TY, Keshavarz-Bahaghighat H, Seubert JM.

Chem Biol Interact. 2019 Aug 1;308:20-44. doi: 10.1016/j.cbi.2019.04.037. Epub 2019 May 5. Review.

3.

The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.

Nelson JR, Raskin S.

Postgrad Med. 2019 May;131(4):268-277. doi: 10.1080/00325481.2019.1607414. Epub 2019 May 7. Review.

PMID:
31063407
4.

Dietary total fat, fatty acids intake, and risk of cardiovascular disease: a dose-response meta-analysis of cohort studies.

Zhu Y, Bo Y, Liu Y.

Lipids Health Dis. 2019 Apr 6;18(1):91. doi: 10.1186/s12944-019-1035-2. Review.

5.

Advances in n-3 polyunsaturated fatty acid nutrition.

Li D, Wahlqvist ML, Sinclair AJ.

Asia Pac J Clin Nutr. 2019;28(1):1-5. doi: 10.6133/apjcn.201903_28(1).0001. Review.

6.

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, AlAbdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L.

Cochrane Database Syst Rev. 2018 Nov 30;11:CD003177. doi: 10.1002/14651858.CD003177.pub4.

PMID:
30521670
7.

The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review.

Pizzini A, Lunger L, Sonnweber T, Weiss G, Tancevski I.

Nutrients. 2018 Dec 2;10(12). pii: E1864. doi: 10.3390/nu10121864. Review.

8.

Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.

Tam KW, Wu MY, Siddiqui FJ, Chan ES, Zhu Y, Jafar TH.

Cochrane Database Syst Rev. 2018 Nov 18;11:CD011353. doi: 10.1002/14651858.CD011353.pub2.

PMID:
30480758
9.

Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies.

Singh NK, Rao GN.

Prog Lipid Res. 2019 Jan;73:28-45. doi: 10.1016/j.plipres.2018.11.001. Epub 2018 Nov 22. Review.

PMID:
30472260
10.

Effects of fatty and lean fish intake on stroke risk: a meta-analysis of prospective cohort studies.

Qin ZZ, Xu JY, Chen GC, Ma YX, Qin LQ.

Lipids Health Dis. 2018 Nov 23;17(1):264. doi: 10.1186/s12944-018-0897-z.

11.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
12.

Pro-resolving lipid mediators: Agents of anti-ageing?

Doyle R, Sadlier DM, Godson C.

Semin Immunol. 2018 Dec;40:36-48. doi: 10.1016/j.smim.2018.09.002. Epub 2018 Oct 4. Review.

PMID:
30293857
13.

Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids.

Adili R, Hawley M, Holinstat M.

Prostaglandins Other Lipid Mediat. 2018 Nov;139:10-18. doi: 10.1016/j.prostaglandins.2018.09.005. Epub 2018 Sep 25. Review.

PMID:
30266534
14.

Omega-3 PUFA attenuate mice myocardial infarction injury by emerging a protective eicosanoid pattern.

Fang X, Cai W, Cheng Q, Ai D, Wang X, Hammock BD, Zhu Y, Zhang X.

Prostaglandins Other Lipid Mediat. 2018 Nov;139:1-9. doi: 10.1016/j.prostaglandins.2018.09.002. Epub 2018 Sep 14. Review.

PMID:
30223037
15.

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.

Nicholls SJ, Lincoff AM, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Pedersen TR, Ridker PM, Ray K, Karlson BW, Lundström T, Wolski K, Nissen SE.

Clin Cardiol. 2018 Oct;41(10):1281-1288. doi: 10.1002/clc.23055. Epub 2018 Sep 28. Review.

16.

Dietary n-6 polyunsaturated fatty acids and cardiovascular disease: Epidemiologic evidence.

Wang DD.

Prostaglandins Leukot Essent Fatty Acids. 2018 Aug;135:5-9. doi: 10.1016/j.plefa.2018.05.003. Epub 2018 May 29. Review.

PMID:
30103933
17.

Omega-3 fatty acids and leukocyte-endothelium adhesion: Novel anti-atherosclerotic actions.

Baker EJ, Yusof MH, Yaqoob P, Miles EA, Calder PC.

Mol Aspects Med. 2018 Dec;64:169-181. doi: 10.1016/j.mam.2018.08.002. Epub 2018 Aug 13. Review.

PMID:
30102930
18.

Nutrients in Fish and Possible Associations with Cardiovascular Disease Risk Factors in Metabolic Syndrome.

Tørris C, Småstuen MC, Molin M.

Nutrients. 2018 Jul 23;10(7). pii: E952. doi: 10.3390/nu10070952. Review.

19.

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, AlAbdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L.

Cochrane Database Syst Rev. 2018 Jul 18;7:CD003177. doi: 10.1002/14651858.CD003177.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Nov 30;11:CD003177.

20.

Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids: Dichotomy between Experimental and Clinical Studies.

Desnoyers M, Gilbert K, Rousseau G.

Mar Drugs. 2018 Jul 10;16(7). pii: E234. doi: 10.3390/md16070234. Review.

Supplemental Content

Loading ...
Support Center